Zum Inhalt springen
IPF Institut für Pharmaökonomische Forschung

Kongress-Archiv

ISPOR 13th Annual European Congress

Prague, Czech Republic 6-9 November 2010

  1. Poster

    Health economic aspects of using serum cystatin C for early detection of chronic kidney disease in type 2 diabetics in Germany (Poster Award)

    E. Walter, L. Lennartz, W. Hofmann, S. Herget-Rosenthal

    Download: Health economic aspects of using serum cystatin C for early detection of chronic kidney disease in type 2 diabetics in Germany (Poster Award)
  2. Poster

    Economic Evaluation of Natlizumab in the treatment of relapsing remitting Multiple Sclerosis in 4 European countries

    C. Brennig, E. Walter, V. Schöllbauer

    Download: Economic Evaluation of Natlizumab in the treatment of relapsing remitting Multiple Sclerosis in 4 European countries
  3. Poster

    Socio-economic Aspects of Testing for Neutralising Antibodies in MS Patients on Interferon beta Treatment in Austria: A Cost of Illness Study

    E. Walter, C. Brennig, V. Schöllbauer, W. Mair, F. Deisenhammer

    Download: Socio-economic Aspects of Testing for Neutralising Antibodies in MS Patients on Interferon beta Treatment in Austria: A Cost of Illness Study
  4. Poster

    Economic Evaluation of DARBEPOETIN ALFA (ARANESP©) Compared to EPOETIN ALFA (ERYPO©) and EPOETIN BETA (NEORECORMON©) in the Treatment of Chemotherapy-induced Anemia (CIA) in Austria

    E. Walter, E. Ribnicsek, L. Kutikova

    Download: Economic Evaluation of DARBEPOETIN ALFA (ARANESP©) Compared to EPOETIN ALFA (ERYPO©) and EPOETIN BETA (NEORECORMON©) in the Treatment of Chemotherapy-induced Anemia (CIA) in Austria